Clinical profile and treatment outcomes of immunoglobulin D associated AL amyloidosis

Br J Haematol. 2013 Sep;162(6):856-8. doi: 10.1111/bjh.12433. Epub 2013 Jun 18.
No abstract available

Keywords: IgD amyloidosis; immunoglobulin D; light chain amyloidosis; rare amyloidosis; systemic AL amyloidosis.

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Amyloidosis / drug therapy*
  • Amyloidosis / immunology*
  • Amyloidosis / pathology
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Cyclophosphamide / therapeutic use
  • Dexamethasone / therapeutic use
  • Doxorubicin / therapeutic use
  • Female
  • Humans
  • Immunoglobulin D / immunology*
  • Male
  • Middle Aged
  • Pyrazines / therapeutic use
  • Thalidomide / therapeutic use
  • Treatment Outcome
  • Vincristine / therapeutic use

Substances

  • Boronic Acids
  • Immunoglobulin D
  • Pyrazines
  • Thalidomide
  • Vincristine
  • Bortezomib
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide